https://bavdegalutamideinhibit....or.com/the-role-asso
Here we present 2 situations of diagnosed medulloblastoma which on re-resection had been noted to be gangliocytoma without heterogeneity, which will be an incredibly unusual incident. 1st client, an 11-year-old son identified as having high-risk (non-WNT, non-SHH) medulloblastoma, had been addressed with near-total medical resection followed by craniospinal radiotherapy with weekly vincristine. Then received upkeep chemotherapy with vincristine, cyclophosphamide, and cisplatin
Like
Comment
Share
